ViiV Healthcare Company v. Gilead Sciences Canada, Inc., 2020 FC 486
Linked as:
Extract
ViiV Healthcare Company v. Gilead Sciences Canada, Inc., 2020 FC 486
No longer available (Autolink)
See the full content of this document
This document cites
- Janssen Inc. v. Teva Canada Ltd. et al., (2015) 475 F.T.R. 238 (FC)
- Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC et al., 2016 FCA 119
- ABB Technology AG et al. v. Hyundai Heavy Industries Co., (2015) 475 N.R. 341 (FCA)
- Teva Canada Ltd. v. Wyeth LLC et al., (2012) 431 N.R. 342 (FCA)
- Pfizer Canada Inc. et al. v. Novopharm Ltd. et al., (2012) 436 N.R. 299 (SCC)